Skystar Bio Pharmaceutical Company (NasdaqCM:SKBI) is seeking acquisitions. Skystar Bio Pharmaceutical is planning to raise $5 million from registered direct offering and plans to use part of proceeds for acquisitions too. Skystar Bio Pharmaceutical said, "The Company shall use a portion of the proceeds of the offering for acquisitions, licenses of new vaccine and aquaculture products, research & development and other general corporate purposes."
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 0 | |
+25.83% | 47.96B | |
+44.70% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- SKBI Stock
- News Skystar Bio-Pharmaceutical Company
- Skystar Bio Pharmaceutical Mulls Acquisitions